ADAT2 and cancer: Our results showed that only the wild-type ADAT2 and not the catalytically inactive mutant form is able to rescue the malignant phenotype (Figure 3C–E), thereby strongly supporting that the tRNA-editing activity of ADAT2 is responsible for the observed cancer cell growth phenotypes.